Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study

Journal of Clinical Oncology

Volumn 30, Issue 9, 2012, Pages 958-964

  Win, Aung Ko ^a   Young, Joanne P ^d   Lindor, Noralane M ^l   Tucker, Katherine M ^e   Ahnen, Dennis J ^m   Young, Graeme P ^f   Buchanan, Daniel D ^d   Clendenning, Mark ^d   Giles, Graham G ^a,c   Winship, Ingrid ^a,b   Macrae, Finlay A ^b   Goldblatt, Jack ^g   Southey, Melissa C ^a   Arnold, Julie ^h   Thibodeau, Stephen N ^l   Gunawardena, Shanaka R ^l   Bapat, Bharati ^i,j   Baron, John A ⁿ   Casey, Graham ^o   Gallinger, Steven ^i,k   Le Marchand, Loïc ^p   Newcomb, Polly A ^q   Haile, Robert W ^o   Hopper, John L ^a   Jenkins, Mark A ^a   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e PRINCE OF WALES HOSPITAL   (Australia)

^f FLINDERS UNIVERSITY   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h AUCKLAND CITY HOSPITAL   (New Zealand)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k CANCER CARE ONTARIO   (Canada)

^l MAYO CLINIC   (United States)

^m UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA   (United States)

^o UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^p UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^q Fred Hutchinson Cancer Research Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; ADENOSINE TRIPHOSPHATASE; DNA BINDING PROTEIN; G T MISMATCH BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CLINICAL TRIAL; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; STOMACH CANCER; TUMOR GENE; AGED; AUSTRALIA; COLORECTAL TUMOR; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MIDDLE AGED; MORTALITY; MUTATION; NEOPLASM; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS; NUCLEAR PROTEINS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84860605783     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.5590     Document Type: Article

References (44)

1. Dunlop MG, Farrington SM, Nicholl I, et al: Population carrier frequency of hMSH2 and hMLH1 mutations. Br J Cancer 83:1643-1645, 2000 (Pubitemid 32001707)
2. Hampel H, de la Chapelle A: The search for unaffected individuals with Lynch syndrome: Do the ends justify the means? Cancer Prev Res 4:1-5, 2011
3. Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004 (Pubitemid 38256271)
4. Järvinen HJ, Aarnio M, Mustonen H, et al: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834, 2000 (Pubitemid 30243745)
5. de Jong AE, Hendriks YM, Kleibeuker JH, et al: Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 130:665-671, 2006 (Pubitemid 43374516)
6. Schmeler KM, Lynch HT, Chen LM, et al: Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354:261-269, 2006 (Pubitemid 43113031)
7. Carayol J, Khlat M, Maccario J, et al: Hereditary non-polyposis colorectal cancer: Current risks of colorectal cancer largely overestimated. J Med Genet 39:335-339, 2002 (Pubitemid 34526354)
8. Taylor DP, Burt RW, Williams MS, et al: Population-based family history-specific risks for colorectal cancer: A constellation approach. Gastroenterology 138:877-885, 2010
9. Pande M, Amos CI, Osterwisch DR, et al: Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome. Cancer Epidemiol Biomarkers Prev 17:2393-2401, 2008
10. Campbell PT, Edwards L, McLaughlin JR, et al: Cytochrome P450 17A1 and catechol O-methyltransferase polymorphisms and age at Lynch syndrome colon cancer onset in Newfound-land. Clin Cancer Res 13:3783-3788, 2007 (Pubitemid 47037582)
11. Felix R, Bodmer W, Fearnhead NS, et al: GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation. Mutat Res 602:175-181, 2006 (Pubitemid 44767850)
12. Krüger S, Engel C, Bier A, et al: The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1. Cancer Lett 252:55-64, 2007 (Pubitemid 46734555)
13. Moisio AL, Sistonen P, Mecklin JP, et al: Genetic polymorphisms in carcinogen metabolism and their association to hereditary nonpolyposis colon cancer. Gastroenterology 115:1387-1394, 1998 (Pubitemid 28545989)
14. Reeves SG, Rich D, Meldrum CJ, et al: IGF1 is a modifier of disease risk in hereditary non-polyposis colorectal cancer. Int J Cancer 123:1339-1343, 2008
15. Talseth-Palmer BA, Brenne IS, Ashton KA, et al: Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome. J Med Genet 48:279-284, 2011
16. Wijnen JT, Brohet RM, van Eijk R, et al: Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome. Gastroenterology 136:131-137, 2009
17. Newcomb PA, Baron J, Cotterchio M, et al: Colon Cancer Family Registry: An international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 16:2331-2343, 2007 (Pubitemid 351196365)
18. Fritz A, Percy C, Jack A, et al: International Classification of Diseases for Oncology (ICD-O) (ed 3). Geneva, Switzerland, WHO, 2000
19. Senter L, Clendenning M, Sotamaa K, et al: The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135:419-428, 2008
20. Southey MC, Jenkins MA, Mead L, et al: Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 23:6524-6532, 2005 (Pubitemid 46190244)
21. Smith L, Tesoriero A, Mead L, et al: Large genomic alterations in hMSH2 and hMLH1 in early-onset colorectal cancer: Identification of a large complex de novo hMLH1 alteration. Clin Genet 70:250-252, 2006 (Pubitemid 44219514)
22. Woods MO, Williams P, Careen A, et al: A new variant database for mismatch repair genes associated with Lynch syndrome. Hum Mutat 28:669-673, 2007 (Pubitemid 47047293)
23. Ou J, Niessen RC, Vonk J, et al: A database to support the interpretation of human mismatch repair gene variants. Hum Mutat 29:1337-1341, 2008
24. Curado MP, Edwards B, Shin HR, et al: Cancer Incidence in Five Continents Vol. IX, IARC Scientific Publications No. 160. Lyon, France, International Agency for Research on Cancer, 2007
25. Gould W: Jackknife estimation. Stata Technical Bull 4:25-29, 1995
26. StataCorp: Stata Statistical Software: Release 11. College Station, TX, StataCorp, 2009
27. Baglietto L, Lindor NM, Dowty JG, et al: Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 102:193-201, 2010
28. Chen S, Wang W, Lee S, et al: Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296:1479-1487, 2006 (Pubitemid 44465512)
29. Aarnio M, Mecklin JP, Aaltonen LA, et al: Life-time risk of different cancers in hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430-433, 1995 (Pubitemid 26048907)
30. Watson P, Lynch HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677-685, 1993 (Pubitemid 23051366)
31. Aarnio M, Sankila R, Pukkala E, et al: Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214-218, 1999 (Pubitemid 29144749)
32. Vasen HF, Stormorken A, Menko FH, et al: MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19:4074-4080, 2001 (Pubitemid 32976695)
33. Hutter P, Couturier A, Scott RJ, et al: Complex genetic predisposition to cancer in an extended HNPCC family with an ancestral hMLH1 mutation. J Med Genet 33:636-640, 1996 (Pubitemid 26270920)
34. Kastrinos F, Mukherjee B, Tayob N, et al: Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302:1790-1795, 2009
35. Canto MI, Goggins M, Yeo CJ, et al: Screening for pancreatic neoplasia in high-risk individuals: An EUS-based approach. Clin Gastroenterol Hepatol 2:606-621, 2004 (Pubitemid 38834045)
36. Lynch HT, Watson P, Kriegler M, et al: Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II). Dis Colon Rectum 31:372-377, 1988
37. Boyd J, Rhei E, Federici MG, et al: Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 53:87-91, 1999 (Pubitemid 29123623)
38. Jensen UB, Sunde L, Timshel S, et al: Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 120:777-782, 2010
39. Shanley S, Fung C, Milliken J, et al: Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Fam Cancer 8:251-255, 2009
40. Walsh MD, Buchanan DD, Cummings MC, et al: Lynch syndrome-associated breast cancers: Clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res 16:2214-2224, 2010
41. Scott RJ, McPhillips M, Meldrum CJ, et al: Hereditary nonpolyposis colorectal cancer in 95 families: Differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 68:118-127, 2001 (Pubitemid 32048366)
42. Domchek SM, Gaudet MM, Stopfer JE, et al: Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast Cancer Res Treat 119:409-414, 2010
43. Korde LA, Mueller CM, Loud JT, et al: No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families. Breast Cancer Res Treat 125:169-173, 2011
44. Kauff ND, Mitra N, Robson ME, et al: Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. J Natl Cancer Inst 97:1382-1384, 2005 (Pubitemid 41487806)